文献速递腹部泌尿生殖CTMR

影像学在肾细胞癌中的作用:多学科视角

Role of Imaging in Renal Cell Carcinoma: A Multidisciplinary Perspective.
PubMed 文献 · Radiographics · 2021-07-16

本文从多学科角度综述影像学在肾细胞癌诊疗中的作用,涵盖不确定肾肿物的CT/MR表征与结构化报告要素、RCC分期中易被忽视的区域(如肾包膜或肾周筋膜侵犯)、局部治疗(手术、消融、栓塞、主动监测、SBRT)及晚期治疗反应评估的影像学价值,并讨论抗血管生成靶向治疗和免疫治疗相关的独特影像表现。

要点

  • CT/MR是表征不确定肾肿物的核心手段,报告应包含基本、重要及可选描述要素。
  • RCC分期需特别关注肾包膜及肾周(Gerota)筋膜侵犯等易漏区域。
  • 靶向和免疫治疗后可出现独特影像表现,治疗反应评估更复杂。

关键影像表现/征象

  • CT或MR图像上完整表征不确定肾肿物具有挑战性,需综合多参数评估。
  • RCC分期中肾包膜或肾周(Gerota)筋膜侵犯在影像上可能被忽视。
  • 抗血管生成靶向治疗和免疫治疗可出现独特的影像学表现。

临床应用与阅片要点

  • 对不确定肾肿物应使用结构化报告,涵盖基本、重要和可选描述要素。
  • 分期阅片时需主动评估肾包膜和肾周筋膜有无侵犯,避免漏诊。
  • 局部治疗决策(手术、消融、栓塞、主动监测、SBRT)需结合影像学特征。
  • 靶向或免疫治疗后评估反应时需注意相关独特影像表现,避免误判。

局限性

  • 本文为综述,未提供系统检索策略或证据分级。
  • 全文基于文献和专家意见,未报告原始研究数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

With the expansion in cross-sectional imaging over the past few decades, there has been an increase in the number of incidentally detected renal masses and an increase in the incidence of renal cell carcinomas (RCCs). The complete characterization of an indeterminate renal mass on CT or MR images is challenging, and the authors provide a critical review of the best imaging methods and essential, important, and optional reporting elements used to describe the indeterminate renal mass. While surgical staging remains the standard of care for RCC, the role of renal mass CT or MRI in staging RCC is reviewed, specifically with reference to areas that may be overlooked at imaging such as detection of invasion through the renal capsule or perirenal (Gerota) fascia. Treatment options for localized RCC are expanding, and a multidisciplinary group of experts presents an overview of the role of advanced medical imaging in surgery, percutaneous ablation, transarterial embolization, active surveillance, and stereotactic body radiation therapy. Finally, the arsenal of treatments for advanced renal cancer continues to grow to improve response to therapy while limiting treatment side effects. Imaging findings are important in deciding the best treatment options and to monitor response to therapy. However, evaluating response has increased in complexity. The unique imaging findings associated with antiangiogenic targeted therapy and immunotherapy are discussed. An invited commentary by Remer is available online. Online supplemental material is available for this article. ©RSNA, 2021.

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Abou Elkassem AM, Lo SS, Gunn AJ, et al. Role of Imaging in Renal Cell Carcinoma: A Multidisciplinary Perspective. Radiographics. 2021. PMID: 34270355. doi:10.1148/rg.2021200202

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。